Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Targeted gene expression profiling predicts meningioma outcomes and radiotherapy responses
William Chen, Abrar Choudhury, Mark W. Youngblood, et al.
Nature Medicine (2023) Vol. 29, Iss. 12, pp. 3067-3076
Open Access | Times Cited: 54

Showing 1-25 of 54 citing articles:

Biomarker-driven molecular imaging probes in radiotherapy
Haonan Li, Qiyong Gong, Kui Luo
Theranostics (2024) Vol. 14, Iss. 10, pp. 4127-4146
Open Access | Times Cited: 78
Meningioma: International Consortium on Meningiomas consensus review on scientific advances and treatment paradigms for clinicians, researchers, and patients
Justin Z. Wang, Alexander Landry, David R. Raleigh, et al.
Neuro-Oncology (2024) Vol. 26, Iss. 10, pp. 1742-1780
Open Access | Times Cited: 28
Molecular classification to refine surgical and radiotherapeutic decision-making in meningioma
Justin Z. Wang, Vikas Patil, Alexander Landry, et al.
Nature Medicine (2024) Vol. 30, Iss. 11, pp. 3173-3183
Open Access | Times Cited: 16
Spatial genomic, biochemical and cellular mechanisms underlying meningioma heterogeneity and evolution
Calixto‐Hope G. Lucas, Kanish Mirchia, Kyounghee Seo, et al.
Nature Genetics (2024) Vol. 56, Iss. 6, pp. 1121-1133
Open Access | Times Cited: 15
cIMPACT-NOW update 8: Clarifications on molecular risk parameters and recommendations for WHO grading of meningiomas
Felix Sahm, Kenneth Aldape, Priscilla K. Brastianos, et al.
Neuro-Oncology (2024) Vol. 27, Iss. 2, pp. 319-330
Open Access | Times Cited: 12
Perivascular NOTCH3+ Stem Cells Drive Meningioma Tumorigenesis and Resistance to Radiotherapy
Abrar Choudhury, Martha A. Cady, Calixto‐Hope G. Lucas, et al.
Cancer Discovery (2024) Vol. 14, Iss. 10, pp. 1823-1837
Closed Access | Times Cited: 8
Meningioma transcriptomic landscape demonstrates novel subtypes with regional associated biology and patient outcome
H. Nayanga Thirimanne, Damian Almiron-Bonnin, Nicholas Nuechterlein, et al.
Cell Genomics (2024) Vol. 4, Iss. 6, pp. 100566-100566
Open Access | Times Cited: 8
Enhancing X‐Ray Sensitization with Multifunctional Nanoparticles
Jiayi Liu, Junyong Wu, Taili Chen, et al.
Small (2024) Vol. 20, Iss. 35
Open Access | Times Cited: 7
EANO guideline on molecular testing of meningiomas for targeted therapy selection
Felix Sahm, Luca Bertero, Sebastian Brandner, et al.
Neuro-Oncology (2024)
Open Access | Times Cited: 6
Radioligand therapies in meningioma – evidence and future directions
Maximilian J. Mair, Émeline Tabouret, Derek R. Johnson, et al.
Neuro-Oncology (2024) Vol. 26, Iss. Supplement_9, pp. S215-S228
Open Access | Times Cited: 5
The Impact of MRI-Defined Extent of Resection Across Meningioma DNA Methylation Groups: Re-Evaluating Surgery in the Era of Meningioma Molecular Classification
Ramin A. Morshed, Minh Nguyen, Abrar Choudhury, et al.
Neurosurgery (2025)
Closed Access
Pan-cancer secreted proteome and skeletal muscle regulation: insight from a proteogenomic data-driven knowledge base
Traci L. Parry, L. Anne Gilmore, Andy V. Khamoui
Functional & Integrative Genomics (2025) Vol. 25, Iss. 1
Closed Access
Patient-Derived Meningioma Organoids: A Reliable Model for Studying Human Tumor Pathophysiology
Youssef M. Zohdy, Arman Jahangiri, Fadi Jacob, et al.
Cancers (2025) Vol. 17, Iss. 3, pp. 526-526
Open Access
Expression of SSTR2a, FAP, HER2 and HER3 as potential radionuclide therapy targets in higher-grade meningioma
Maximilian J. Mair, Sabrina Hartenbach, Erwin Tomasich, et al.
European Journal of Nuclear Medicine and Molecular Imaging (2025)
Open Access
Advances of Artificial Intelligence in Clinical Application and Scientific Research of Neuro-oncology: Current Knowledge and Future Perspectives
Yihong Zhan, Yuanyue Hao, Xiang Wang, et al.
Critical Reviews in Oncology/Hematology (2025), pp. 104682-104682
Open Access
Meningioma: Novel Diagnostic and Therapeutic Approaches
Carlen Yuen, M.Y. Zheng, Max A. Saint-Germain, et al.
Biomedicines (2025) Vol. 13, Iss. 3, pp. 659-659
Open Access
Topographic Patterns of Intracranial Meningioma Recurrences—Systematic Review with Clinical Implication
Sergio Corvino, Roberto Altieri, Giuseppe La Rocca, et al.
Cancers (2024) Vol. 16, Iss. 12, pp. 2267-2267
Open Access | Times Cited: 3
RNA splicing as a biomarker and phenotypic driver of meningioma DNA-methylation groups
Nathan K. Leclair, Abrar Choudury, William Chen, et al.
Neuro-Oncology (2024) Vol. 26, Iss. 12, pp. 2222-2236
Open Access | Times Cited: 3
Cost-Effectiveness Analysis of68Ga-DOTATATE PET/MRI in Radiotherapy Planning in Patients with Intermediate-Risk Meningioma
José A. Rodriguez, Gabriela Martinez, Sean S. Mahase, et al.
American Journal of Neuroradiology (2023) Vol. 44, Iss. 7, pp. 783-791
Open Access | Times Cited: 9
Systematic characterization of antibody–drug conjugate targets in central nervous system tumors
Shannon Coy, J. Lee, Sabrina J. Chan, et al.
Neuro-Oncology (2023) Vol. 26, Iss. 3, pp. 458-472
Closed Access | Times Cited: 9
Efficacy and toxicity of bimodal radiotherapy in WHO grade 2 meningiomas following subtotal resection with carbon ion boost: Prospective phase 2 MARCIE trial
Maximilian Deng, Sybren L. N. Maas, Felix Hinz, et al.
Neuro-Oncology (2023) Vol. 26, Iss. 4, pp. 701-712
Closed Access | Times Cited: 7
The Evolving Classification of Meningiomas: Integration of Molecular Discoveries to Inform Patient Care
S. Joy Trybula, Mark W. Youngblood, Constantine L. Karras, et al.
Cancers (2024) Vol. 16, Iss. 9, pp. 1753-1753
Open Access | Times Cited: 2
Investigating the Radiobiological Response to Peptide Receptor Radionuclide Therapy Using Patient-Derived Meningioma Spheroids
Thom G. A. Reuvers, Vivian Grandia, Renata M. C. Brandt, et al.
Cancers (2024) Vol. 16, Iss. 14, pp. 2515-2515
Open Access | Times Cited: 2
Gene Expression Changes Associated With Recurrence After Gross Total Resection of Newly Diagnosed World Health Organization Grade 1 Meningioma
Ramin A. Morshed, Minh Nguyen, Mark W. Youngblood, et al.
Neurosurgery (2024)
Closed Access | Times Cited: 2
Enhancing neuro-oncology care through equity-driven applications of artificial intelligence
Mulki Mehari, Youssef Sibih, Abraham Dada, et al.
Neuro-Oncology (2024) Vol. 26, Iss. 11, pp. 1951-1963
Closed Access | Times Cited: 2
Page 1 - Next Page

Scroll to top